Medications

What is Zepbound? A Complete Guide to This New Weight Loss Medication

If you've been following weight loss medication news, you've likely heard about Zepbound. Approved by the FDA in November 2023, it's the newest option in a growing family of medications that's changing how we approach weight management. But what exactly is Zepbound, how does it work, and could it be right for you?

Let's break down everything you need to know about this medication in straightforward terms.

What is Zepbound?

Zepbound is the brand name for tirzepatide when it's prescribed specifically for weight loss. You might recognize tirzepatide by another name—Mounjaro—which is the same medication but approved for treating type 2 diabetes.

It's a once-weekly injection that you give yourself at home, similar to how insulin pens work but much simpler. The medication comes in a pre-filled pen that you inject under your skin in your abdomen, thigh, or upper arm.

The FDA approved Zepbound for adults with obesity (BMI of 30 or greater) or those who are overweight (BMI of 27 or greater) with at least one weight-related health condition like high blood pressure, type 2 diabetes, or high cholesterol.

How Does Zepbound Work?

Zepbound is what's called a dual agonist. That's medical speak for a medication that activates two different receptors in your body: GLP-1 and GIP.

Here's what that means in practical terms:

GLP-1 Action

Like other medications in this class, Zepbound activates GLP-1 receptors. This helps slow down how quickly food leaves your stomach, reduces your appetite, and helps regulate blood sugar levels. You feel fuller longer and have fewer cravings.

GIP Action

This is where Zepbound differs from medications like Wegovy or Ozempic. By also activating GIP receptors, it may enhance how your body processes fat and improve insulin sensitivity. Some research suggests this dual action might lead to more weight loss compared to GLP-1-only medications.

The combination helps your body work with you instead of against you when you're trying to lose weight.

Zepbound Dosing and Administration

Zepbound follows a gradual dose escalation schedule. This means you start low and slowly increase over time, which helps your body adjust and minimizes side effects.

The typical dosing schedule looks like this:

Your healthcare provider will work with you to find the right maintenance dose. Not everyone needs to reach the maximum dose—the goal is finding what works best for your body and gives you results with manageable side effects.

Expected Weight Loss Results

In clinical trials, people taking Zepbound lost significant amounts of weight. At the highest doses, participants lost an average of 15-20% of their body weight over 72 weeks when combined with diet and exercise.

To put that in perspective, someone weighing 240 pounds might lose 36-48 pounds on average. Of course, individual results vary. Some people lose more, some less, depending on factors like starting weight, lifestyle changes, and how their body responds to the medication.

Results don't happen overnight. Most people start noticing weight loss within the first few weeks, but meaningful results typically build over several months of consistent use.

Gender Considerations

Clinical trials showed that both women and men experienced significant weight loss with Zepbound, though women made up the majority of study participants. Some research suggests women may experience slightly more gastrointestinal side effects initially, while men might see faster initial weight loss due to differences in metabolism and body composition. However, both genders achieve substantial results with consistent use.

Common Side Effects

Like all medications, Zepbound can cause side effects. The most common ones are digestive:

These side effects are usually worst when you first start or increase your dose, and they typically improve over time as your body adjusts. Starting at a low dose and increasing gradually helps minimize these effects.

Less common but more serious side effects can include pancreatitis, gallbladder problems, and changes in vision. There's also a boxed warning about thyroid C-cell tumors based on animal studies, though this hasn't been seen in humans.

Who Shouldn't Take Zepbound

Zepbound isn't right for everyone. You shouldn't take it if you:

Always discuss your complete medical history with your healthcare provider before starting any weight loss medication.

Zepbound vs. Other Weight Loss Medications

You might be wondering how Zepbound compares to other options like Wegovy (semaglutide) or Saxenda (liraglutide).

Zepbound's dual-action mechanism theoretically gives it an edge, and some head-to-head studies suggest greater average weight loss compared to semaglutide-based medications. However, individual response varies—some people do better on one medication versus another.

The "best" medication is the one that works for your body, fits your lifestyle, and has side effects you can manage.

Cost and Availability

Zepbound can be expensive, with list prices over $1,000 per month without insurance. Insurance coverage varies widely, and many plans require prior authorization or have specific criteria you must meet.

The manufacturer offers a savings card that may reduce costs for eligible patients with commercial insurance. For those without coverage or who face high costs, compounded versions of tirzepatide may be available at lower prices through specialized pharmacies.

From the Ozari Care Team

Starting any weight loss medication works best when combined with sustainable lifestyle changes. We recommend focusing on protein-rich meals and staying well-hydrated, especially during the first few weeks as your body adjusts. Remember that slower, steady weight loss tends to be more sustainable than rapid drops, so be patient with the process and yourself.

Ready to Start Your Weight Loss Journey?

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.


Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026